The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 196 | 2016 |
MethyCancer: the database of human DNA methylation and cancer X He, S Chang, J Zhang, Q Zhao, H Xiang, K Kusonmano, L Yang, ... Nucleic acids research 36 (suppl_1), D836-D841, 2007 | 165 | 2007 |
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer E Birkeland, E Wik, S Mjøs, EA Hoivik, J Trovik, HMJ Werner, ... British journal of cancer 107 (12), 1997-2004, 2012 | 100 | 2012 |
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions IL Tangen, HMJ Werner, A Berg, MK Halle, K Kusonmano, J Trovik, ... European journal of cancer 50 (17), 3003-3010, 2014 | 91 | 2014 |
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas HMJ Werner, A Berg, E Wik, E Birkeland, C Krakstad, K Kusonmano, ... Modern Pathology 26 (3), 428-434, 2013 | 82 | 2013 |
Draft genome sequence of Arthrospira platensis C1 (PCC9438) S Cheevadhanarak, K Paithoonrangsarid, P Prommeenate, W Kaewngam, ... Standards in genomic Sciences 6, 43-53, 2012 | 74 | 2012 |
Lipocalin 2 expression is associated with aggressive features of endometrial cancer M Mannelqvist, IM Stefansson, E Wik, K Kusonmano, MB Raeder, ... BMC cancer 12, 1-7, 2012 | 66 | 2012 |
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors H Engerud, IL Tangen, A Berg, K Kusonmano, MK Halle, AM Øyan, ... British journal of cancer 111 (1), 78-84, 2014 | 65 | 2014 |
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients A Berg, EA Hoivik, S Mjøs, F Holst, HMJ Werner, IL Tangen, ... Oncotarget 6 (2), 1327, 2015 | 63 | 2015 |
HER2 expression patterns in paired primary and metastatic endometrial cancer lesions MK Halle, IL Tangen, HF Berg, EA Hoivik, KK Mauland, K Kusonmano, ... British journal of cancer 118 (3), 378-387, 2018 | 58 | 2018 |
High phospho-Stathmin (Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition E Wik, E Birkeland, J Trovik, HMJ Werner, EA Hoivik, S Mjos, C Krakstad, ... Clinical cancer research 19 (9), 2331-2341, 2013 | 51 | 2013 |
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study MK Halle, AI Ojesina, H Engerud, K Woie, IL Tangen, F Holst, E Høivik, ... American journal of obstetrics and gynecology 217 (4), 432. e1-432. e17, 2017 | 45 | 2017 |
Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism L Mak, S Liggi, L Tan, K Kusonmano, J M Rollinger, A Koutsoukas, ... Current pharmaceutical design 19 (4), 532-577, 2013 | 45 | 2013 |
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma C Krakstad, IL Tangen, EA Hoivik, MK Halle, A Berg, HM Werner, ... Oncotarget 6 (29), 28440, 2015 | 43 | 2015 |
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated C Krakstad, E Birkeland, D Seidel, K Kusonmano, K Petersen, S Mjøs, ... PloS one 7 (12), e52795, 2012 | 42 | 2012 |
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene EA Hoivik, K Kusonmano, MK Halle, A Berg, E Wik, HMJ Werner, ... Oncotarget 5 (4), 1052, 2014 | 40 | 2014 |
Informatics for metabolomics K Kusonmano, W Vongsangnak, P Chumnanpuen Translational Biomedical Informatics: A Precision Medicine Perspective, 91-115, 2016 | 34 | 2016 |
Switch in FOXA1 status associates with endometrial cancer progression IL Tangen, C Krakstad, MK Halle, HMJ Werner, AM Øyan, K Kusonmano, ... PloS one 9 (5), e98069, 2014 | 31 | 2014 |
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer S Mjos, HMJ Werner, E Birkeland, F Holst, A Berg, MK Halle, IL Tangen, ... Scientific reports 7 (1), 10240, 2017 | 26 | 2017 |
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma F Holst, HMJ Werner, S Mjøs, EA Hoivik, K Kusonmano, E Wik, A Berg, ... Clinical Cancer Research 25 (1), 334-345, 2019 | 24 | 2019 |